Connection

Bilun Gemicioglu to Humans

Back to Details
This is a "connection" page, showing publications Bilun Gemicioglu has written about Humans.
Bilun Gemicioglu
Connection Strength
0.047
Humans
  1. The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD. J Asthma. 2020 12; 57(12):1273-1279.
    View in: PubMed
    Score: 0.007
  2. Clinical challenges in elderly asthma. Tuberk Toraks. 2019 Mar; 67(1):31-38.
    View in: PubMed
    Score: 0.006
  3. Asthma control and adherence in newly diagnosed young and elderly adult patients with asthma in Turkey. J Asthma. 2019 05; 56(5):553-561.
    View in: PubMed
    Score: 0.006
  4. Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
    View in: PubMed
    Score: 0.002
  5. Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism. Ann Nucl Med. 2021 Oct; 35(10):1117-1125.
    View in: PubMed
    Score: 0.002
  6. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus. Allergy. 2021 08; 76(8):2354-2366.
    View in: PubMed
    Score: 0.002
  7. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. Respir Med. 2021 07; 183:106433.
    View in: PubMed
    Score: 0.002
  8. Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19. Int Arch Allergy Immunol. 2021; 182(4):324-338.
    View in: PubMed
    Score: 0.002
  9. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital. BMC Infect Dis. 2021 Feb 05; 21(1):148.
    View in: PubMed
    Score: 0.002
  10. Spices to Control COVID-19 Symptoms: Yes, but Not Only…. Int Arch Allergy Immunol. 2021; 182(6):489-495.
    View in: PubMed
    Score: 0.002
  11. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.002
  12. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol. 2019 07; 144(1):135-143.e6.
    View in: PubMed
    Score: 0.002
  13. A Retrospective Analysis of Anaerobic Bacteria Isolated in 236 Cases of Pleural Empyema and their Prevalance of Antimicrobial Resistance in Turkey. Clin Lab. 2018 Jul 01; 64(7):1269-1277.
    View in: PubMed
    Score: 0.002
  14. [MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity]. Tuberk Toraks. 2018 Jun; 66(2):176-181.
    View in: PubMed
    Score: 0.002
  15. Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial. Int Arch Allergy Immunol. 2018; 176(3-4):225-233.
    View in: PubMed
    Score: 0.002
  16. Real life profile of asthma and chronic obstructive pulmonary disease patients in Turkey. Tuberk Toraks. 2017 Sep; 65(3):169-179.
    View in: PubMed
    Score: 0.001
  17. [Assessing the knowledge in primary health care following an educational course structured in the context of GARD chronic airway diseases national control program]. Tuberk Toraks. 2017 Jun; 65(2):80-89.
    View in: PubMed
    Score: 0.001
  18. [Turkish Thoracic Society national spirometry and laboratory standards]. Tuberk Toraks. 2017 Jun; 65(2):117-130.
    View in: PubMed
    Score: 0.001
  19. [ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle]. Tuberk Toraks. 2017 Mar; 65(1):32-40.
    View in: PubMed
    Score: 0.001
  20. Evaluation of laryngeal findings in users of inhaled steroids. Eur Arch Otorhinolaryngol. 2010 Jun; 267(6):917-23.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.